Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. - Wikidata - awgldk - TriplyDB

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

http://www.wikidata.org/entity/Q35499647

about

Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?Evidence for the prevention and treatment of stroke in dialysis patients 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients Intersection of cardiovascular disease and kidney disease: atrial fibrillation.The debate on warfarin use in dialysis patients with atrial fibrillation: more fuel for the fire.Heparin use in hemodialysis patients following gastrointestinal bleeding.Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation Risk of Stroke in Patients with ESRD Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.Ischemic stroke among the patients with end-stage renal disease who were undergoing maintenance dialysis Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).A hemodialysis cohort study of protocol-based anticoagulation management.Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Meta-Analysis Atrial fibrillation and risk of stroke in dialysis patients.Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation.Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.Evidence-based cardiology in hemodialysis patients Use and safety of heparin-free maintenance hemodialysis in the USA.Risk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction.Management of Atrial Fibrillation in Patients With Kidney Disease.Anticoagulants in atrial fibrillation patients with chronic kidney disease.Anticoagulants in patients with atrial fibrillation and end-stage renal disease.Changing the hemodialysis prescription for hemodialysis patients with subdural and intracranial hemorrhage.Vitamin K antagonists: beyond bleeding.2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation.Antithrombotic medications in dialysis patients: a double-edged sword.Cardiovascular complications in chronic dialysis patients.Atrial fibrillation and chronic kidney disease: struggling through thick and thin.Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease.Antithrombotic therapy in end-stage renal disease.Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.

P2860

Q26782013-6778E8BF-9CF3-4B6E-B61B-3CAF734BC4EB Q26827576-BC8321D5-227D-4A5E-A614-FAF3897A4525 Q27002491-75DEAB2C-F412-4F32-8F60-205CFBBF4D42 Q27009350-E6334413-F627-4DA4-B96E-A8F7F2A32FEB Q27010464-4ED6B637-7209-4B60-AB07-9256114370EA Q27023274-AEE2B984-F311-47EB-B9C1-D23AEAFEECCA Q27341873-59A20C72-8EEC-4EC9-ADCC-49E25A3F7B5F Q33617196-69BF911D-16D7-41BF-8250-2EFF3DA8337F Q34040279-B33FAAB0-70A0-4AAE-AB7E-45CB56FAB3C9 Q34403796-E5D3D3BC-CC83-4A1E-85FC-43C283A9E07D Q34580144-0E75BA83-43A8-4926-988F-80AF0762A4FD Q35055177-AD6F5097-41D4-4A43-BF53-933586F0CCA7 Q36025660-70535CFF-2706-4B29-9023-7DA9413C2639 Q36069462-14F06E1A-2AFA-46C6-AB68-1FFA732473CC Q36096144-11A7D4F7-DDAE-4D88-BDB7-5B5166D02E61 Q36171135-BA787DDA-191D-4711-9B5F-2F197BE67204 Q36178116-E77E02D2-49DA-4D5C-8429-81E32B7972B2 Q36239524-AAC2FBFE-DE53-4D4D-890E-6205C7F537C8 Q36261765-8ADB8C86-A96D-4461-AEBA-448C711A068C Q36353636-E5A3CB3A-FA9A-4166-9F9A-9F8A67A2C3B2 Q36581021-F2BC0B63-B998-4BB4-A09C-123FE2F17AA8 Q36605061-F108D0EA-205F-4A37-8D04-FE676A2BA073 Q36897127-E4F4AA94-AD56-4CE6-9A7C-770484288F47 Q37115706-9866359E-C84D-4E94-9CCA-5C3BEE275E65 Q37340239-178E1C2C-260C-4286-8045-FF425DD4B317 Q37464192-4839E868-8211-4040-941C-C15863DAC10B Q37468787-A5342594-65F4-4CB6-8D8C-D0330CBCB091 Q37469045-0170B8C8-33A6-4740-A275-C8090DB884CA Q38028855-0C6112ED-F95D-4529-B08F-7E7A2A813B3E Q38074333-A5DC48FB-0EE4-46A8-B5FD-2FE7D8FF5F02 Q38153434-68065C24-AD6D-4524-9DA2-DC5ECC9578FE Q38176662-85069C7F-12CA-45E3-A8C1-0224355AB6AE Q38647787-0196C71E-68F4-4216-BF88-FB83D1854B9E Q38683015-4DC46A34-8577-453F-AEB6-F2D86C266841 Q38918821-45BCA016-C5BE-4C5C-8FFC-69FF43BBD231 Q38956399-1F33B156-F9C7-4C86-A101-504425F18422 Q38981275-B6DD482F-46E4-425B-8024-567923523EB3 Q39000809-97089C38-9097-47CC-AD7E-551452F03106 Q39329927-3551053E-BCC5-40CA-9F18-CD39153787B7 Q39864511-7C993583-3709-4305-BED7-4319B51100A0

P2860

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

http://www.wikidata.org/entity/Q35499647

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effectiveness and safety of wa ...... incident atrial fibrillation.

@ast

Effectiveness and safety of wa ...... incident atrial fibrillation.

@en

type

label

Effectiveness and safety of wa ...... incident atrial fibrillation.

@ast

Effectiveness and safety of wa ...... incident atrial fibrillation.

@en

prefLabel

Effectiveness and safety of wa ...... incident atrial fibrillation.

@ast

Effectiveness and safety of wa ...... incident atrial fibrillation.

@en

P1433

Q35499647-CEBCB995-A6F0-4C9B-93CD-B708AED6A8BC

P1476

Q35499647-C579BE6D-6E0A-4D9E-8782-C34BA776807C

P2093

Q35499647-13AFAB74-A9C2-404C-A938-5C7BC3859CB8

Q35499647-9F2028F5-D512-45C5-838E-89745F294CEA

Q35499647-A96C539D-B47D-4020-9B70-9FF9C4D7A276

Q35499647-AF67B58D-5769-4960-BDEA-A71C0842DF9D

P2860

Q35499647-0BD7952F-C368-41B4-82A9-3AB4EDB1DBBD

Q35499647-0FDAD088-9C04-4968-AE34-074068024F76

Q35499647-1E68CA73-4986-4F32-B049-43D91BB9F6AF

Q35499647-1ED73C9D-E5D7-4ED8-BDC4-7925FB61DE2D

Q35499647-21D014BB-0010-4561-838C-426812B4B721

Q35499647-32754C14-F4B0-4ABE-8D9A-3A2B6C0CE869

Q35499647-44EFFA33-595C-4AE9-8781-3AD698F03884

Q35499647-6EEDDDA4-D68B-464E-BC5F-F7E8BEDC17C6

Q35499647-9AF9910C-97EF-4AD3-84D0-6218F2219C03

Q35499647-B3AC6897-3CC8-465F-AEF1-BA2D3C9C5D7F

P304

Q35499647-602441BF-A36E-4AFC-B513-8EC6B0CAA274

P31

Q35499647-58A3FDC4-3B8A-4C40-9084-61C916B47AE4

P356

Q35499647-D9BFFE43-1A9C-4C12-8A11-84AD0FE5162B

P433

Q35499647-A549BF10-3B66-46CA-A843-0B2B8F26863D

P478

Q35499647-3E0DC13A-FA57-4A1B-AEC4-522CBD499529

P577

Q35499647-5375B2BF-BE59-4DA0-BD6D-A2D85228BC9F

P5875

Q35499647-D7C2F17C-4E8C-4C04-AC81-425D7653C827

P698

Q35499647-F486BED7-80D8-4D3D-AE28-D4D45BD8AA86

P921

Q35499647-64D22E2C-C2FA-4A3B-926E-AA4EB5019969

P932

Q35499647-C1B04ACE-5FAA-4624-9E3E-4FD15F581B91

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Effectiveness and safety of wa ...... incident atrial fibrillation.

@en

P2093

Jun Liu

http://www.w3.org/2001/XMLSchema#string

Niteesh K Choudhry

http://www.w3.org/2001/XMLSchema#string

Soko Setoguchi

http://www.w3.org/2001/XMLSchema#string

Wolfgang C Winkelmayer

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality

Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients

The increasing prevalence of atrial fibrillation among hemodialysis patients.

Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.

Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.

P304

2662-2668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.04550511

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51681811

http://www.w3.org/2001/XMLSchema#string

P698

21959598

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

3206003

http://www.w3.org/2001/XMLSchema#string